Balance Sheet
Cash Flow Statement
Net Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innate Pharma (IPHA) Change in Cash (2019 - 2024)

Historic Change in Cash for Innate Pharma (IPHA) over the last 6 years, with Q4 2024 value amounting to -$4.5 million.

  • Innate Pharma's Change in Cash rose 6930.56% to -$4.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$33.1 million, marking a year-over-year increase of 3298.06%. This contributed to the annual value of -$4.5 million for FY2024, which is 6930.56% up from last year.
  • As of Q4 2024, Innate Pharma's Change in Cash stood at -$4.5 million, which was up 6930.56% from -$1076.9 recorded in Q2 2024.
  • Innate Pharma's Change in Cash's 5-year high stood at -$1076.9 during Q2 2024, with a 5-year trough of -$78.8 million in Q4 2020.
  • In the last 5 years, Innate Pharma's Change in Cash had a median value of -$17.3 million in 2023 and averaged -$28.9 million.
  • Per our database at Business Quant, Innate Pharma's Change in Cash plummeted by 228042.03% in 2020 and then surged by 9999.23% in 2024.
  • Over the past 5 years, Innate Pharma's Change in Cash (Quarter) stood at -$78.8 million in 2020, then surged by 52.04% to -$37.8 million in 2021, then soared by 47.27% to -$19.9 million in 2022, then rose by 26.47% to -$14.7 million in 2023, then surged by 69.31% to -$4.5 million in 2024.
  • Its Change in Cash stands at -$4.5 million for Q4 2024, versus -$1076.9 for Q2 2024 and -$14.7 million for Q4 2023.